Richard Samulski
Fondateur chez Asklepios BioPharmaceutical, Inc.
Profil
Richard Jude Samulski is the founder of Beacon Therapeutics (USA), Inc. (founded in 1999), Brain Neurotherapy Bio, Inc. (founded in 2018), Jurata Thin Film, Inc. (founded in 2019), and Asklepios BioPharmaceutical, Inc. (founded in 2001).
He is also the founder of Merlin Corp.
Dr. Samulski's current job is as a Director at Viralgen Vector Core SL.
His former jobs include being a Director-Scientific Advisory at Avigen, Inc., a Director at The University of North Carolina at Charlotte, the President of NanoCor Therapeutics, Inc., a Member of the US Food & Drug Administration, and a Principal at The FDA Alliance.
Dr. Samulski's education includes a doctorate from the University of Florida.
Dr. Samulski is also the founder of Merlin Corp...
Postes actifs de Richard Samulski
| Sociétés | Poste | Début |
|---|---|---|
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Fondateur | 01/01/2001 |
Viralgen Vector Core SL
 Viralgen Vector Core SL BiotechnologyHealth Technology Viralgen Vector Core SL is a contract development and manufacturing organization (CDMO) that produces AAV gene therapy treatments for pharmaceutical and biotech companies. The company was founded in 2017 by Javier García Cogorro and is based in Donostia-San Sebastian, Spain. Viralgen offers the Pro10™ based suspension manufacturing platform, which increases scalability, performance, and yield of AAV therapies. The Spanish company's clinical facilities have four CGMP manufacturing suites, with 250-liter and 500-liter bioreactors. In 2020, Viralgen expanded within the scientific park by constructing a new building for large-scale commercial manufacturing. The new state-of-the-art space includes three additional CGMP suites with a manufacturing capacity of >2,000 liters each, as well as a suite dedicated to fully automated fill and finish operations. The new facility has received the CGMP certification by the Spanish Agency for Medicines and Medical Devices (AEMPS) as part of the EMA network. The CEO is Jimmy Vanhove. | Directeur/Membre du Conseil | - |
Anciens postes connus de Richard Samulski
| Sociétés | Poste | Fin |
|---|---|---|
Jurata Thin Film, Inc.
 Jurata Thin Film, Inc. Air Freight/CouriersTransportation Jurata Thin Film, Inc. is a privately-held biotechnology company located in the US that aims to revolutionize the manufacturing, storage, distribution, and delivery of vaccines and biologics. The American company's technology has been proven to protect cargo even when exposed to extreme temperatures, potentially removing the need for cold chain logistics in vaccine and biologic transport and storage. Jurata's thin films have the potential to store therapeutics at room temperature for up to three years prior to reconstitution and up to eight months after reconstitution while maintaining therapeutic payload potency. | Fondateur | - |
Bamboo Therapeutics, Inc.
 Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | Fondateur | - |
Brain Neurotherapy Bio, Inc.
 Brain Neurotherapy Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Brain Neurotherapy Bio, Inc. develops transformative neurological gene therapies that restore and preserve health and well-being. The company was founded by Krystof S. Bankiewicz, Sheila Mikhail and Jude R. Samulski in 2018 and is headquartered in Research Triangle Park, NC. | Fondateur | - |
| The University of North Carolina at Charlotte | Directeur/Membre du Conseil | - |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Corporate Officer/Principal | - |
Formation de Richard Samulski
| University of Florida | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Health Technology |
NanoCor Therapeutics, Inc.
 NanoCor Therapeutics, Inc. BiotechnologyHealth Technology NanoCor Therapeutics, Inc. provides biotechnology products and services. It focuses on treating cardiovascular disease at the molecular level. The company was founded by Roger A. Hajjar, Sheila A. Mikhail, and Gabor M. Rubanyi in 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Health Technology |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
Merlin Corp.
 Merlin Corp. Other Consumer ServicesConsumer Services Merlin Corp. provides automobile services. Its services include suspension system repair, wheel alignment, starter work, tires, fuel injection cleaning and changing belts and hoses. The company was founded by Richard J. Samulski and Dana M. Fowlkes in 1975 and is headquartered in DeKalb, IL. | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
| The FDA Alliance | |
Bamboo Therapeutics, Inc.
Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | Health Technology |
Viralgen Vector Core SL
Viralgen Vector Core SL BiotechnologyHealth Technology Viralgen Vector Core SL is a contract development and manufacturing organization (CDMO) that produces AAV gene therapy treatments for pharmaceutical and biotech companies. The company was founded in 2017 by Javier García Cogorro and is based in Donostia-San Sebastian, Spain. Viralgen offers the Pro10™ based suspension manufacturing platform, which increases scalability, performance, and yield of AAV therapies. The Spanish company's clinical facilities have four CGMP manufacturing suites, with 250-liter and 500-liter bioreactors. In 2020, Viralgen expanded within the scientific park by constructing a new building for large-scale commercial manufacturing. The new state-of-the-art space includes three additional CGMP suites with a manufacturing capacity of >2,000 liters each, as well as a suite dedicated to fully automated fill and finish operations. The new facility has received the CGMP certification by the Spanish Agency for Medicines and Medical Devices (AEMPS) as part of the EMA network. The CEO is Jimmy Vanhove. | Health Technology |
Brain Neurotherapy Bio, Inc.
Brain Neurotherapy Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Brain Neurotherapy Bio, Inc. develops transformative neurological gene therapies that restore and preserve health and well-being. The company was founded by Krystof S. Bankiewicz, Sheila Mikhail and Jude R. Samulski in 2018 and is headquartered in Research Triangle Park, NC. | Commercial Services |
Jurata Thin Film, Inc.
Jurata Thin Film, Inc. Air Freight/CouriersTransportation Jurata Thin Film, Inc. is a privately-held biotechnology company located in the US that aims to revolutionize the manufacturing, storage, distribution, and delivery of vaccines and biologics. The American company's technology has been proven to protect cargo even when exposed to extreme temperatures, potentially removing the need for cold chain logistics in vaccine and biologic transport and storage. Jurata's thin films have the potential to store therapeutics at room temperature for up to three years prior to reconstitution and up to eight months after reconstitution while maintaining therapeutic payload potency. | Transportation |